ASCENDIS PHARMA A/S
ASND · NASDAQ
Updated at 2026-10-14 09:52:58
- Today's High
- $228.91
- Today’s Low
- $222.21
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $229.00
- Previous Close
- $227.00
- Volume
- 667.44K
- Market Cap
- $14.15B
- P/E Ratio
- 17.24X
- EPS
- $11.03
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- TUBORG BOULEVARD 12, HELLERUP, DENMARK, 2900
- Country
- DK
- Listing Date
- 2015-01-28
- Fiscal Year End
- December
- Shares Outstanding
- 66.19M
- CIK
- 0001612042
- Website
- ascendispharma.dk
Ascendis Pharma A / S, a biopharmaceutical company, develops therapies for unmet medical needs. The company is headquartered in Hellerup, Denmark.
Financial Metrics
Revenue
2026-06-30
$344.9M
2026-03-31
$250.65M
2025-12-31
$245.17M
2025-09-30
$213.63M
Operating Expenses
2026-06-30
$249.17M
2026-03-31
$203.81M
2025-12-31
$208.17M
2025-09-30
$180.28M
Net Income
2026-06-30
$210.39M
2026-03-31
$639.68M
2025-12-31
-$33.24M
2025-09-30
-$60.98M
Net Profit Margin
2026-06-30
61%
2026-03-31
255.2%
2025-12-31
-13.56%
2025-09-30
-28.54%
Earnings Per Share
2026-06-30
$3.29
2026-03-31
$0.27
2025-12-31
$-0.55
2025-09-30
$-1.00
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$68.07M
2026-03-31
$23.68M
2025-12-31
$39.72M
2025-09-30
-$53.35M
Effective Tax Rate
2026-06-30
10.04%
2026-03-31
1.4K%
2025-12-31
-25.67%
2025-09-30
-6.3%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $344.9M | $250.65M | $245.17M | $213.63M |
| Operating Expenses | $249.17M | $203.81M | $208.17M | $180.28M |
| Net Income | $210.39M | $639.68M | -$33.24M | -$60.98M |
| Net Profit Margin | 61% | 255.2% | -13.56% | -28.54% |
| Earnings Per Share | $3.29 | $0.27 | $-0.55 | $-1.00 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $68.07M | $23.68M | $39.72M | -$53.35M |
| Effective Tax Rate | 10.04% | 1.4K% | -25.67% | -6.3% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.